Host Dendritic Cells in Allograft Patients

NCT00935597 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Relapsed Non-Hodgkin's Lymphoma
Hodgkin's Disease
Multiple Myeloma
Chronic Lymphocytic Lymphoma

Interventions

BIOLOGICAL: MSSM/BIIR HDC Vax-001 (Host Dendritic Cells)

Sponsor

Icahn School of Medicine at Mount Sinai